XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.80

-0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (13918)	7/2/2000 10:47:02 AM
From: aknahow	Read Replies (1) of 17367

Cacaito, I don't believe I haver tried to put words in your mouth, or insist you were saying something other than what you really meant. Perhaps you misunderstand me. 1. I am not saying Neuprex worked in the Trauma trial. The trial failed. I am saying the trial did not prove Neuprex does not work, IF the 50% reduction of incidents in the placebo group is true. 2. I am not saying XOMA is involved in any way in the production of LLY's Protein C. I am saying XOMA owes us a yes or no because LLY has a license to the cell expression technology and it was obtained considerably before LLY to its product into clinic. 3. I am not saying failure is better than success but only that given the many regulatory hurdles and past failures, (SCIOS even had a positive recommendation from the FDA committee), I am surprised at anyone canting victory before the battle is actually won.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next